<DOC>
	<DOCNO>NCT02705053</DOCNO>
	<brief_summary>This clinical trial study assess performance automate glucose control system ( Artificial Pancreas , AP ) device home setting subject type 1 diabetes . Specifically , investigator test zone model predictive control AP enhance run-to-run optimization basal rate ( BR ) insulin carbohydrate ratio ( CR ) .</brief_summary>
	<brief_title>At Home Study Zone-Model Predictive Control ( MPC ) Controller Health Monitoring System ( HMS ) With Diabetes Assistant ( DiAs ) System Run-to-Run Adaptation</brief_title>
	<detailed_description>This clinical trial study assess performance automate glucose control system ( Artificial Pancreas , AP ) device home setting subject type 1 diabetes . Specifically , investigator test zone model predictive control AP enhance run-to-run optimization basal rate ( BR ) insulin carbohydrate ratio ( CR ) . This protocol build investigator previously validate Zone-MPC Health Monitoring System ( HMS ) algorithm ( ClinicalTrials.gov : NCT01929798 ) integrate Diabetes Assistant ( DiAs ) system ( ClinicalTrials.gov : NCT02463682 ) . The AP system use NCT02463682 use algorithmic adjustment CR 's prior closed-loop initiation , continue BR CR algorithmic optimization closed-loop use long duration . The system evaluate 12 subject per site ( n=36 subject ) 15 week 3 different site ( William Sansum Diabetes Center , University Virginia , Mayo Clinic , Rochester , MN ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis , base investigator assessment , type 1 diabetes least one year use insulin least 1 year insulin pump least 6 month Willing wear study CGM device duration study Age ≥21 &lt; 65 year HbA1c &lt; 10.0 % ; HbA1c &lt; 6.0 % total daily insulin must ≥0.5 U/kg For female , currently know pregnant . If female sexually active , must agree use form contraception prevent pregnancy participant study . A negative urine pregnancy test require premenopausal woman surgically sterile . Subjects become pregnant discontinue study . Demonstration proper mental status cognition study Currently use insulintocarbohydrate ratio calculate meal bolus size Hypoglycemia awareness demonstrate Clarke Hypoglycemia Unawareness score 2 low Access internet cell phone service home , computer download device data Availability care partner commit participate training activity , knowledgeable time participant 's location , available provide assistance system use night Commitment maintaining uninterrupted availability via cell phone avoid overnight travel duration period use closedloop system An understanding willingness follow protocol sign inform consent Admission diabetic ketoacidosis 12 month prior enrollment Severe hypoglycemia result seizure loss consciousness 12 month prior enrollment History seizure disorder ( except hypoglycemic seizure ) , unless write clearance receive neurologist Coronary artery disease heart failure , unless write clearance receive cardiologist History cardiac arrhythmia ( except benign premature atrial contraction benign premature ventricular contraction permit ) Cystic fibrosis A known medical condition judgment investigator might interfere completion protocol follow example : 1 . Inpatient psychiatric treatment past 6 month either subject subject 's primary care giver ( i.e. , parent guardian ) 2 . Presence known adrenal disorder 3 . Abnormal liver function test result ( Transaminase &gt; 2 time upper limit normal ) ; test require subject take medication know affect liver function diseases know affect liver function 4 . Abnormal renal function test result ( calculated GFR &lt; 60 mL/min/1.73m2 ) ; test require subject diabetes duration great 5 year post onset puberty 5 . Active gastroparesis 6 . If antihypertensive , thyroid , antidepressant lipid lower medication , lack stability medication past 2 month prior enrollment study 7 . Uncontrolled thyroid disease ( TSH undetectable &gt; 10 mlU/L ) ; test require within three month prior admission subject goiter thyroid hormone replacement , within one year otherwise 8 . Abuse alcohol recreational drug 9 . Infectious process anticipate resolve prior study procedure ( e.g . meningitis , pneumonia , osteomyelitis ) A recent injury body limb , muscular disorder , use medication , carcinogenic disease , significant medical disorder injury , medication disease judgment investigator affect completion protocol Current use follow drug supplement : 1 . Acetaminophen 2 . Beta blocker 3 . Oral injectable glucocorticoid 4 . Any medication investigator believe contraindication subject 's participation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>Artificial Pancreas</keyword>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>